🔎 Trials Near Me

Utama › Penyakit Paru Interstisial › Indiana

Kajian klinikal Penyakit Paru Interstisial di Indiana

6 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi di Indiana.

Bandar di Indiana

Teks kajian rasmi (Bahasa Inggeris)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • Indiana University Health Enterprise Clinical Research Operation, Indianapolis
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07540988

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • Indiana University, Indianapolis
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Indiana University Health Methodist Hospital, Indianapolis
  • Community Health Network, Indianapolis
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • St. Vincent Cardiovascular Research Institute, Indianapolis
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Ascension St. Vincent, Indianapolis
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Vincent Medical Group, Indianapolis
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 80 · Semua jantina · Dikemas kini 26 Jun 2026 · NCT06129240

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.